Abstract:BACKGROUND:Breast tumor heterogeneity is related to risk factors that lead to worse prognosis, yet such heterogeneity has not been well studied.PURPOSE:To predict the Ki-67 status of estrogen receptor (ER)-positive breast cancer patients via analysis of tumor heterogeneity with subgroup identification based on patterns of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).STUDY TYPE:Retrospective study.POPULATION:Seventy-seven breast cancer patients with ER-positive breast cancer were investigated, of whom 51 had low Ki-67 expression.FIELD STRENGTH/SEQUENCE:T1 -weighted 3.0T DCE-MR images.ASSESSMENT:Each tumor was partitioned into multiple subregions using three methods based on patterns of dynamic enhancement: 1) time to peak (TTP), 2) peak enhancement rate (PER), and 3) kinetic pattern clustering (KPC). In each tumor subregion, 18 texture features were computed.STATISTICAL TESTING:Univariate and multivariate logistic regression analyses were performed using a leave-one-out-based cross-validation (LOOCV) method. The partitioning results were compared with the same feature extraction methods across the whole tumor.RESULTS:In the univariate analysis, the best-performing feature was the texture statistic of sum variance in the tumor subregion with early TTP for differentiating between patients with high and low Ki-67 expression (area under the receiver operating characteristic curves, AUC = 0.748). Multivariate analysis showed that features from the tumor subregion associated with early TTP yielded the highest performance (AUC = 0.807) among the subregions for predicting the Ki-67 status. Among all regions, the tumor area with high PER at a precontrast MR image achieved the highest performance (AUC = 0.722), while the subregion that exhibited the highest overall enhancement rate based on KPC had an AUC of 0.731. These three models based on intratumoral texture analysis significantly (P < 0.01) outperformed the model using features from the whole tumor (AUC = 0.59).DATA CONCLUSION:Texture analysis of intratumoral heterogeneity has the potential to serve as a valuable clinical marker to enhance the prediction of breast cancer prognosis.LEVEL OF EVIDENCE:4 Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2017.

Heterogeneity Of Tumor And Its Surrounding Stroma On Dce-Mri And Diffusion Weighted Imaging In Predicting Histological Grade And Lymph Node Status Of Breast Cancer

Prediction of Histological Grade and Ki-67 Expression in Breast Cancer by DCE-MRI and DWI Features

Prediction of Histological Grade in Breast Cancer by Combining DCE-MRI and DWI Features

Analysis of DCE-MRI features in tumor and the surrounding stroma for prediction of Ki-67 proliferation status in breast cancer

Diffusion-weighted Imaging Features of Breast Tumours and the Surrounding Stroma Reflect Intrinsic Heterogeneous Characteristics of Molecular Subtypes in Breast Cancer

Quantitative diffusion weighted imaging parameters in tumor and peritumoral stroma for prediction of molecular subtypes in breast cancer

Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.

DCE-MRI Based Analysis of Intratumor Heterogeneity by Decomposing Method for Prediction of HER2 Status in Breast Cancer.

Correlation of Dynamic Contrast-Enhanced MRI and Diffusion-Weighted MR Imaging with Prognostic Factors and Subtypes of Breast Cancers.

DCE-MRI Texture Analysis with Tumor Subregion Partitioning for Predicting Ki-67 Status of Estrogen Receptor-Positive Breast Cancers.

Association Between Dynamic Contrast Enhanced MRI Imaging Features and WHO Histopathological Grade in Patients with Invasive Ductal Breast Cancer.

Prediction and Prognosis of Biologically Aggressive Breast Cancers by the Combination of DWI/DCE-MRI and Immunohistochemical Tumor Markers.

Predictive Ability of DWI/ADC and DCE-MRI Kinetic Parameters in Differentiating Benign from Malignant Breast Lesions and in Building a Prediction Model.

Intratumor Heterogeneity of DCE-MRI Reveals Ki-67 Proliferation Status in Breast Cancer

Analysis of DCE-MRI Features in Tumor for Prediction of the Prognosis in Breast Cancer

The use of dynamic contrast enhanced MRI in differentiating between benign and malignant breast tumors and predicting the histologic grade for breast cancer patients

Value of magnetic resonance imaging radiomics features in predicting histologic grade of invasive ductal carcinoma of the breast

Radiomic Analysis Reveals DCE-MRI Features for Prediction of Molecular Subtypes of Breast Cancer.

Heterogeneity of Diffusion-Weighted Imaging in Tumours and the Surrounding Stroma for Prediction of Ki-67 Proliferation Status in Breast Cancer

Radiomic Analysis of Pharmacokinetic Heterogeneity Within Tumor Based on the Unsupervised Decomposition of Dynamic Contrast-Enhanced MRI for Predicting Histological Characteristics of Breast Cancer

Radiogenomic analysis of breast cancer: Dynamic contrast enhanced - Magnetic resonance imaging based features are associated with molecular subtypes